These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26480992)

  • 1. Conservative Management of Intentional Massive Dabigatran Overdose.
    Mumoli N; Cei M; Fiorini M; Pennati P; Testa S; Dentali F
    J Am Geriatr Soc; 2015 Oct; 63(10):2205-7. PubMed ID: 26480992
    [No Abstract]   [Full Text] [Related]  

  • 2. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
    Sié P
    Drug Des Devel Ther; 2016; 10():1683-9. PubMed ID: 27274201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive outcome after intentional overdose of dabigatran.
    Woo JS; Kapadia N; Phanco SE; Lynch CA
    J Med Toxicol; 2013 Jun; 9(2):192-5. PubMed ID: 23212788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.
    Taune V; Wallén H; Ågren A; Gryfelt G; Sjövik C; Wintler AM; Malmström RE; Wikman A; Skeppholm M
    Thromb Res; 2017 May; 153():76-82. PubMed ID: 28347811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectivity of hemodialysis in acute gastrointestinal bleeding associated with dabigatran overdose.
    Kilit C; Erarslan S; Pasali Kilit T
    Acta Gastroenterol Belg; 2017; 80(2):322. PubMed ID: 29560702
    [No Abstract]   [Full Text] [Related]  

  • 6. Massive eucalyptus oil overdose.
    Young S; O'Driscoll R; Antony M; Whyte I
    Intern Med J; 2017 Sep; 47(9):1085-1086. PubMed ID: 28891175
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB; Husted SE; Vang ML
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idarucizumab (Praxbind)--an antidote for dabigatran.
    Med Lett Drugs Ther; 2015 Nov; 57(1482):157-8. PubMed ID: 26583604
    [No Abstract]   [Full Text] [Related]  

  • 9. Dabigatran Concentration: Variability and Potential Bleeding Prediction In "Real-Life" Patients With Atrial Fibrillation.
    Šinigoj P; Malmström RE; Vene N; Rönquist-Nii Y; Božič-Mijovski M; Pohanka A; Antovic JP; Mavri A
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):323-9. PubMed ID: 25981948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review.
    Adcock DM; Gosselin R
    Thromb Res; 2015 Jul; 136(1):7-12. PubMed ID: 25981138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Dabigatran Levels: What Tests Are Available and What Still Needs to Be Done?
    Chan NC; Weitz JI
    Thromb Haemost; 2017 Dec; 117(12):2213-2214. PubMed ID: 29212109
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in gastrointestinal decontamination for deliberate self poisoning in Christchurch.
    Ardagh M; Balasingam A
    N Z Med J; 1996 Dec; 109(1035):462-3. PubMed ID: 9006625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening coagulation tests are underutilised in patients on dabigatran presenting with thromboembolic or haemorrhagic events.
    Chin PK; Fox A; Marais M; Tiong J
    Intern Med J; 2016 Feb; 46(2):240-1. PubMed ID: 26899894
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].
    Panchenko EP
    Kardiologiia; 2011; 51(11):83-90. PubMed ID: 22117775
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monitoring of coagulation during treatment with direct oral anticoagulants].
    Kasper A; Lindhoff-Last E
    Dtsch Med Wochenschr; 2013 Oct; 138(40):1997-2000. PubMed ID: 24065404
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
    Douxfils J; Lessire S; Dincq AS; Hjemdahl P; Rönquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogné JM; Mullier F
    Thromb Haemost; 2015 Apr; 113(4):862-9. PubMed ID: 25519251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute colchicine overdose: report of three cases.
    Aghabiklooei A; Zamani N; Hassanian-Moghaddam H; Nasouhi S; Mashayekhian M
    Reumatismo; 2014 Mar; 65(6):307-11. PubMed ID: 24705036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
    Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
    Bouchard J; Ghannoum M; Bernier-Jean A; Williamson D; Kershaw G; Weatherburn C; Eris JM; Tran H; Patel JP; Roberts DM
    Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotational thromboelastometry in ex vivo samples from routine clinical practice patients receiving dabigatran.
    Božič-Mijovski M; Vene N; Snoj N; Gradišek P; Mavri A
    Clin Chim Acta; 2017 Mar; 466():20-21. PubMed ID: 28069400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.